Share URL
Embed chart view
StockViz
Clarity Pharmaceuticals Ltd
ASX:CU6.AX
Sector
Industries
Location
Market Cap
USD 831.35 M
Share Price
USD 2.24
Avg Daily Volume
3,415,911
Change (1 day)
-10.82%
Change (1 year)
-45.85%
Change (YTD)
-13.27%
Clarity Pharmaceuticals Ltd Enterprise Value to EBITDA (EV/EBITDA) on August 20, 2025
Clarity Pharmaceuticals Ltd Enterprise Value to EBITDA (EV/EBITDA) is NA on August 20, 2025. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
-
Clarity Pharmaceuticals Ltd 52-week low Enterprise Value to EBITDA (EV/EBITDA) is NA on August 20, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Clarity Pharmaceuticals Ltd 52-week low Enterprise Value to EBITDA (EV/EBITDA) is NA on August 20, 2025, which is NA below the current Enterprise Value to EBITDA (EV/EBITDA).
-
Clarity Pharmaceuticals Ltd average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is NA.
Competitors
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Thermo Fisher Scientific Inc.
USD 498.29
TMO
+10.75
2.21%
Amgen Inc.
USD 295.55
AMGN
+2.93
1.00%
Gilead Sciences, Inc.
USD 117.98
GILD
-0.01
-0.01%
Pfizer Inc.
USD 25.32
PFE
+0.25
1.00%
Sanofi
USD 100.73
SAN.PA
+0.93
0.94%
Vertex Pharmaceuticals Incorporated
USD 390.76
VRTX
+0.88
0.23%
Bristol-Myers Squibb Company
USD 48.34
BMY
+0.15
0.31%
Chugai Pharmaceutical Co., Ltd.
USD 43.52
4519.T
-0.76
-1.72%
Key Data
| Date | Enterprise Value to EBITDA (EV/EBITDA) | Free Cash Flow Yield | Dividend Yield | Market Capitalization |
|---|
Competitors
Eli Lilly and Company
USD 703.21
LLY
+5.16
0.74%
AbbVie Inc.
USD 206.19
ABBV
-0.38
-0.18%
Roche Holding AG
USD 337.32
RO.SW
+4.54
1.36%
Novo Nordisk A/S
USD 54.16
NOVO-B.CO
-0.02
-0.03%
Novartis AG
USD 124.85
NOVN.SW
+0.78
0.63%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Merck & Co., Inc.
USD 84.93
MRK
+0.71
0.84%
Thermo Fisher Scientific Inc.
USD 498.29
TMO
+10.75
2.21%
Amgen Inc.
USD 295.55
AMGN
+2.93
1.00%
Gilead Sciences, Inc.
USD 117.98
GILD
-0.01
-0.01%
Pfizer Inc.
USD 25.32
PFE
+0.25
1.00%
Sanofi
USD 100.73
SAN.PA
+0.93
0.94%
Vertex Pharmaceuticals Incorporated
USD 390.76
VRTX
+0.88
0.23%
Bristol-Myers Squibb Company
USD 48.34
BMY
+0.15
0.31%
Chugai Pharmaceutical Co., Ltd.
USD 43.52
4519.T
-0.76
-1.72%